CutisPharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$29,872
Doctors Paid
2
Transactions
17
2019 Total
$2,933
Payment Breakdown by Category
Research$17,849 (59.8%)
Consulting$9,210 (30.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $17,849 | 2 | 59.8% |
| Consulting Fee | $9,210 | 14 | 30.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,813 | 1 | 9.4% |
Payments by Type
Research
$17,849
2 transactions
General
$12,023
15 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| In-vitro activity of vancomycin hydrochloride oral solutions (RM-01) compared to Sigma Aldrich vancomycin HCl standard against Clostridium difficile and Staphylococcus aureus | $17,849 | 0 | 2 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Infectious Disease | $12,023 | 2 | $6,011 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Rakhi Kohli, M.d, M.D | Infectious Disease | Boston, MA | $9,210 | $0 |
| Yoav Golan, M.d, M.D | Infectious Disease | Boston, MA | $2,813 | $0 |
About CutisPharma, Inc.
CutisPharma, Inc. has made $29,872 in payments to 2 healthcare providers, recorded across 17 transactions in the CMS Open Payments database. In 2019, the company paid $2,933. The top product by payment volume is FIRVANQ ($27,872).
Payments were distributed across 1 medical specialties. The top specialty by payment amount is Infectious Disease ($12,023 to 2 doctors).
Payment categories include: Consulting ($9,210), Research ($17,849).